Cargando…

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings

INTRODUCTION: HIV cohort data from high-income European countries were compared with the UNAIDS Spectrum modelling parameters for these same countries to validate mortality rates and excess mortality estimates for people living with HIV (PLHIV) on antiretroviral therapy (ART). METHODS: Data from 200...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trickey, Adam, van Sighem, Ard, Stover, John, Abgrall, Sophie, Grabar, Sophie, Bonnet, Fabrice, Berenguer, Juan, Wyen, Christoph, Casabona, Jordi, d’Arminio Monforte, Antonella, Cavassini, Matthias, del Amo, Julia, Zangerle, Robert, Gill, M. John, Obel, Niels, Sterne, Jonathan A.C., May, Margaret T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919232/ https://www.ncbi.nlm.nih.gov/pubmed/31800404 http://dx.doi.org/10.1097/QAD.0000000000002387

Ejemplares similares

Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies
por: Trickey, Adam, et al.
Publicado: (2020)

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
por: Trickey, Adam, et al.
Publicado: (2016)

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
por: Kaulich-Bartz, Josee, et al.
Publicado: (2013)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients
por: Ingle, Suzanne M., et al.
Publicado: (2014)

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study
por: May, Margaret T., et al.
Publicado: (2016)

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
por: Helleberg, Marie, et al.
Publicado: (2015)

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation
por: Pettit, April C, et al.
Publicado: (2018)

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study
por: Trickey, Adam, et al.
Publicado: (2022)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Role of In Vitro Stimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients
por: Tincati, Camilla, et al.
Publicado: (2012)

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
por: Gras, Luuk, et al.
Publicado: (2019)

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2011)

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers
por: Chereau, Fanny, et al.
Publicado: (2017)

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023)

sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
por: Loosli, Tom, et al.
Publicado: (2023)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges
por: Gourlay, Annabelle, et al.
Publicado: (2017)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4
por: Grabar, Sophie, et al.
Publicado: (2017)

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection
por: Lodi, Sara, et al.
Publicado: (2022)

Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
por: Ingle, Suzanne M, et al.
Publicado: (2023)

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis
por: Girardi, Enrico, et al.
Publicado: (2012)

Reply to Manfredi
por: Lichtner, Miriam, et al.
Publicado: (2015)

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy
por: Saracino, Annalisa, et al.
Publicado: (2018)

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?
por: Vourli, Georgia, et al.
Publicado: (2020)

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy
por: Di Biagio, Antonio, et al.
Publicado: (2016)

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders
por: Giancola, Maria Letizia, et al.
Publicado: (2012)

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
por: Saracino, Annalisa, et al.
Publicado: (2014)

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
por: Mondi, Annalisa, et al.
Publicado: (2019)

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study
por: Caniglia, Ellen C., et al.
Publicado: (2016)

Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice
por: Costarelli, Silvia, et al.
Publicado: (2016)

Efficient immune reconstitution in HIV+ naïve patients (pts) starting a first lopinavir/ritonavir-containing regimen with low CD4 counts
por: Merlini, E, et al.
Publicado: (2010)

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
por: d’Arminio Monforte, Antonella, et al.
Publicado: (2020)

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2016)

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus
por: Mussini, Cristina, et al.
Publicado: (2015)

Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
por: Merlini, Esther, et al.
Publicado: (2021)

Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy
por: Lodwick, Rebecca K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_adta712u5a55860ss7a8740hr7